Clinical Trials Directory

Trials / Completed

CompletedNCT05897242

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Detailed description

OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the ACT on Vaping smartphone app and text messaging program and receive incentivized text messages assessing their vaping status. ARM II: Participants receive incentivized text messages check-ins assessing their vaping status.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmartphone appUse ACT on Vaping smartphone app
OTHERText MessageReceive text messages
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2024-01-04
Primary completion
2024-04-26
Completion
2024-04-26
First posted
2023-06-09
Last updated
2025-06-24
Results posted
2025-06-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05897242. Inclusion in this directory is not an endorsement.